X0306 4 2014-10-31 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001323113 Swisher Daniel N JR C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Stock Option (Right to Buy) 1.70 2014-10-31 4 A 0 300000 0 A 2024-10-31 Common Stock 300000 300000 D One-forty-eighth (1/48th) of the shares subject to the stock option shall vest in equal monthly installments over forty-eight (48) months measured from the Option Grant Date; provided, that at each such vesting date, the optionee shall then be providing Service (as defined in the Plan) to the Company. This stock option shall be subject to the vesting acceleration benefits under such optionee's respective Executive Severance Benefits Agreement. /s/ David Tucker (Attorney-in-Fact) 2014-11-02